rs1800038

Variant summary

Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP4_ModerateBP7BA1

The NM_000681.4(ADRA2A):​c.1138C>A​(p.Arg380Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0288 in 1,602,504 control chromosomes in the GnomAD database, including 4,179 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.053 ( 610 hom., cov: 33)
Exomes 𝑓: 0.026 ( 3569 hom. )

Consequence

ADRA2A
NM_000681.4 synonymous

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.374

Publications

13 publications found
Variant links:
Genes affected
ADRA2A (HGNC:281): (adrenoceptor alpha 2A) Alpha-2-adrenergic receptors are members of the G protein-coupled receptor superfamily. The alpha-2-adrenergic receptors are a type of adrenergic receptors (for adrenaline or epinephrine), which inhibit adenylate cyclase. These receptors include 3 highly homologous subtypes: alpha2A, alpha2B, and alpha2C. They are involved in regulating the release of neurotransmitter molecules from sympathetic nerves and from adrenergic neurons in the central nervous system. The sympathetic nervous system regulates cardiovascular function by activating adrenergic receptors in the heart, blood vessels and kidney. Studies in mouse revealed that both the alpha2A and alpha2C receptor subtypes were required for presynaptic transmitter release from the sympathetic nervous system in the heart and from central noradrenergic neurons. The alpha-2-adrenergic receptors are also involved in catecholamine signaling by extracellular regulated protein kinase 1 and 2 (ERK1/2) pathways. A clear association between the alpha-2-adrenergic receptor and disease has not been yet established. [provided by RefSeq, Sep 2019]
ADRA2A Gene-Disease associations (from GenCC):
  • lipodystrophy
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • lipodystrophy, familial partial, type 8
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -11 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.36).
BP7
Synonymous conserved (PhyloP=0.374 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.293 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ADRA2ANM_000681.4 linkc.1138C>A p.Arg380Arg synonymous_variant Exon 1 of 1 ENST00000280155.4 NP_000672.3 P08913

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ADRA2AENST00000280155.4 linkc.1138C>A p.Arg380Arg synonymous_variant Exon 1 of 1 6 NM_000681.4 ENSP00000280155.2 P08913

Frequencies

GnomAD3 genomes
AF:
0.0528
AC:
8033
AN:
152024
Hom.:
601
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0752
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.151
Gnomad ASJ
AF:
0.000576
Gnomad EAS
AF:
0.306
Gnomad SAS
AF:
0.0751
Gnomad FIN
AF:
0.0170
Gnomad MID
AF:
0.0191
Gnomad NFE
AF:
0.00540
Gnomad OTH
AF:
0.0547
GnomAD2 exomes
AF:
0.0738
AC:
17900
AN:
242440
AF XY:
0.0654
show subpopulations
Gnomad AFR exome
AF:
0.0797
Gnomad AMR exome
AF:
0.219
Gnomad ASJ exome
AF:
0.00186
Gnomad EAS exome
AF:
0.319
Gnomad FIN exome
AF:
0.0176
Gnomad NFE exome
AF:
0.00581
Gnomad OTH exome
AF:
0.0432
GnomAD4 exome
AF:
0.0263
AC:
38074
AN:
1450366
Hom.:
3569
Cov.:
31
AF XY:
0.0262
AC XY:
18841
AN XY:
720282
show subpopulations
African (AFR)
AF:
0.0779
AC:
2589
AN:
33224
American (AMR)
AF:
0.215
AC:
9535
AN:
44342
Ashkenazi Jewish (ASJ)
AF:
0.00109
AC:
28
AN:
25778
East Asian (EAS)
AF:
0.302
AC:
11901
AN:
39446
South Asian (SAS)
AF:
0.0653
AC:
5592
AN:
85636
European-Finnish (FIN)
AF:
0.0152
AC:
763
AN:
50212
Middle Eastern (MID)
AF:
0.0218
AC:
125
AN:
5734
European-Non Finnish (NFE)
AF:
0.00464
AC:
5128
AN:
1106040
Other (OTH)
AF:
0.0402
AC:
2413
AN:
59954
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.513
Heterozygous variant carriers
0
1867
3734
5600
7467
9334
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
568
1136
1704
2272
2840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0530
AC:
8065
AN:
152138
Hom.:
610
Cov.:
33
AF XY:
0.0580
AC XY:
4315
AN XY:
74384
show subpopulations
African (AFR)
AF:
0.0752
AC:
3127
AN:
41556
American (AMR)
AF:
0.152
AC:
2330
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.000576
AC:
2
AN:
3470
East Asian (EAS)
AF:
0.305
AC:
1575
AN:
5162
South Asian (SAS)
AF:
0.0753
AC:
364
AN:
4832
European-Finnish (FIN)
AF:
0.0170
AC:
180
AN:
10560
Middle Eastern (MID)
AF:
0.0171
AC:
5
AN:
292
European-Non Finnish (NFE)
AF:
0.00540
AC:
367
AN:
67964
Other (OTH)
AF:
0.0546
AC:
115
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
362
724
1086
1448
1810
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
88
176
264
352
440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0165
Hom.:
51
Bravo
AF:
0.0650
Asia WGS
AF:
0.179
AC:
619
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.36
CADD
Benign
9.8
DANN
Benign
0.96
PhyloP100
0.37
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1800038; hg19: chr10-112838892; COSMIC: COSV54527202; API